Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.
Sec. Gynecological Oncology
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1458019
This article is part of the Research Topic Insights, Controversies, and New Developments in the Initial Treatment Decisions for Advanced Epithelial Ovarian Cancer View all 3 articles

Pathological PCI as a prognostic marker of survival after neoadjuvant chemotherapy in patients undergoing interval cytoreduction with or without HIPEC in FIGO stage IIIC high grade serous ovarian cancer

Provisionally accepted
Snita Sinukumar Snita Sinukumar 1*Dileep Damodaran Dileep Damodaran 2Deepika S Deepika S 2Sanjay Piplani Sanjay Piplani 1
  • 1 Jehangir Hospital, Pune, India
  • 2 MVR Cancer Centre and Research Institute, Calicut, Kerala, India

The final, formatted version of the article will be published soon.

    Objective: To determine the best possible value of pathological PCI (pPCI) as a prognostic marker for survival in high grade serous epithelial ovarian cancer patients in patients treated with neoadjuvant chemotherapy and interval cytoreductive surgery, Method: All patients with FIGO stage IIIC high grade serous carcinoma of ovary were included. Receiver operating curves (ROC) were applied to the best possible score of pPCI in predicting survival. Survival curves were calculated using the Kaplan-Meier test and factors affecting survival was compared using the log rank test.Results: From Jan 2018 to Jan 2024, 171 patients undergoing interval cytoreductive surgery were included. A complete cytoreduction was obtained in 88% patients. ROC Curves, determined a (pPCI) cut off value of 8 as the best possible score in predicting survival with a sensitivity of 82% and specificity of 67% .(Youden's Index =0.60). pPCI with a cut off value of 8 showed improved OS ( p=0.002) and DFS, (p=0.001) in both univariate and multivariate analysis .Following interval cytoreductive, surgery despite an optimal complete cytoreductive surgery, a pathological PCI of 8 is a poor prognostic indicators of survival and may serve as a surrogate clinical marker for guiding clinicians for adjuvant treatment especially in the real world resource driven setting.Despite a complete cytoreduction after NACT, pathological PCI of 8 is a poor prognostic indicator of survival.

    Keywords: Pathological PCI, Interval cytoreductive surgery, High grade serous ovarian cancer, HIPEC, KELIM

    Received: 01 Jul 2024; Accepted: 29 Jul 2024.

    Copyright: © 2024 Sinukumar, Damodaran, S and Piplani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Snita Sinukumar, Jehangir Hospital, Pune, India

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.